119 related articles for article (PubMed ID: 7537915)
1. Partial inhibition of platelet aggregation and fibrinogen binding by a murine monoclonal antibody to GPIIIa: requirement for antibody bivalency.
Kutok JL; Coller BS
Thromb Haemost; 1994 Dec; 72(6):964-72. PubMed ID: 7537915
[TBL] [Abstract][Full Text] [Related]
2. A novel mechanism for exposure of fibrinogen binding sites on GPIIb-IIIa by a monoclonal antibody.
Hato T; Watanabe A; Nakatani S; Minamoto Y; Fujita S
Thromb Haemost; 1995 Jan; 73(1):138-43. PubMed ID: 7537917
[TBL] [Abstract][Full Text] [Related]
3. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
4. Exposure of platelet fibrinogen receptors by a monoclonal antibody to the GPIIb-IIIa complex, PMA4.
Watanabe A; Hato T; Kobayashi Y
Int J Hematol; 1992 Aug; 56(1):79-87. PubMed ID: 1382664
[TBL] [Abstract][Full Text] [Related]
5. [Identification of human platelet specific functional antibody and its fragments].
Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
Shido K; Ahmad G; Hsu L; Kamiyama M
J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric observations on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb-IIIa.
Christopoulos C; Mackie I; Lahiri A; Machin S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):729-37. PubMed ID: 8292722
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
[TBL] [Abstract][Full Text] [Related]
9. Effects of IgG and its F(ab')2 fragments of some patients with idiopathic thrombocytopenic purpura on platelet aggregation.
Chu XX; Hou M; Peng J; Zhu YY; Ji XB; Wang L; Zhang F; Ma DX
Eur J Haematol; 2006 Feb; 76(2):153-9. PubMed ID: 16405437
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of thrombocyte aggregation by F(ab')2-fragments of monoclonal antibodies FraMon (CRC64) to glycoproteins IIb-IIIa].
Mazurov AV; Pevzner DV; Khaspekova SG; Dudnik OA; Byzova TV; Vlasik TN; Bakharev VN; Pistsov MIu; Staroverov II; Ruda MIa
Ter Arkh; 2001; 73(9):66-73. PubMed ID: 11642086
[TBL] [Abstract][Full Text] [Related]
11. A humanized antibody specific for the platelet integrin gpIIb/IIIa.
Co MS; Yano S; Hsu RK; Landolfi NF; Vasquez M; Cole M; Tso JT; Bringman T; Laird W; Hudson D
J Immunol; 1994 Mar; 152(6):2968-76. PubMed ID: 8144896
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of GPIIb- and GPIIIa-specific monoclonal antibodies. Further evidence for the existence of agonist-specific activated states of the platelet fibrinogen receptor.
de Castellarnau C; Cullaré C; Alvarez MV; Muñiz-Diez E; Calzada MJ; González-Rodríguez J
Platelets; 1997; 8(4):243-53. PubMed ID: 16793655
[TBL] [Abstract][Full Text] [Related]
13. [Anti-platelet antibody and platelet function].
Kurata Y; Tomiyama Y
Nihon Rinsho; 1992 Feb; 50(2):287-91. PubMed ID: 1377291
[TBL] [Abstract][Full Text] [Related]
14. The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules.
Tomiyama Y; Tsubakio T; Piotrowicz RS; Kurata Y; Loftus JC; Kunicki TJ
Blood; 1992 May; 79(9):2303-12. PubMed ID: 1373972
[TBL] [Abstract][Full Text] [Related]
15. Effects of injected antibody against the platelet glycoprotein IIb/IIIa complex on monkey platelet fibrinogen.
Suzuki M; Kawakatsu T; Nagata H; Hamamoto K; Iwata K; Ohga S; Nomura S; Kokawa T; Yasunaga K
Thromb Haemost; 1992 May; 67(5):578-81. PubMed ID: 1519218
[TBL] [Abstract][Full Text] [Related]
16. Differential inhibition of fibrinogen binding to agonist- and RGDS peptide-activated states of GPIIb-IIIa by an anti-GPIIIa monoclonal antibody, PMA5.
Nakatanl S; Hato T; Minamoto Y; Fujita S
Thromb Haemost; 1996 Dec; 76(6):1030-7. PubMed ID: 8972028
[TBL] [Abstract][Full Text] [Related]
17. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
18. Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I.
Arvieux J; Roussel B; Pouzol P; Colomb MG
Thromb Haemost; 1993 Aug; 70(2):336-41. PubMed ID: 8236145
[TBL] [Abstract][Full Text] [Related]
19. Natural antibodies against the immunoglobulin F(ab')2 fragment cause elimination of antigens recognized by the F(ab')2 from the circulation.
Yano S; Kaku S; Suzuki K; Terazaki C; Sakayori T; Kawasaki T; Kawamura K; Sugita Y; Hoshino K; Masuho Y
Eur J Immunol; 1995 Nov; 25(11):3128-33. PubMed ID: 7489753
[TBL] [Abstract][Full Text] [Related]
20. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]